Jeffrey Molldrem
Keine laufenden Positionen mehr
Karriereverlauf von Jeffrey Molldrem
Ehemalige bekannte Positionen von Jeffrey Molldrem
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
The Vaccine Co.
 The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.01.2003 | - |
| Gründer | 01.11.2009 | - | |
| Corporate Officer/Principal | 01.07.2003 | 01.11.2009 |
Ausbildung von Jeffrey Molldrem
| University of Minnesota | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Director/Board Member | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
The Vaccine Co.
The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Jeffrey Molldrem
- Erfahrung
